Sichuan Huiyu Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2025: 6.64%

Sichuan Huiyu Pharmaceutical Co Ltd asset resilience ratio. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has an Asset Resilience Ratio of 6.64% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sichuan Huiyu Pharmaceutical Co Ltd (688553) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥323.67 Million

≈ $47.36 Million USD Cash + Short-term Investments

Total Assets

CN¥4.88 Billion

≈ $713.55 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Sichuan Huiyu Pharmaceutical Co Ltd (2019–2024)

Asset resilience ratio of Sichuan Huiyu Pharmaceutical Co Ltd from 2019 to 2024. This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 688553 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sichuan Huiyu Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sichuan Huiyu Pharmaceutical Co Ltd assets under control.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥323.67 Million	6.64%
Total Liquid Assets	CN¥323.67 Million	6.64%

Asset Resilience Insights

Limited Liquidity: Sichuan Huiyu Pharmaceutical Co Ltd maintains only 6.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sichuan Huiyu Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Sichuan Huiyu Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	29.37%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
HPGC Renmintongtai Pharmaceutical Corp SHG:600829	Drug Manufacturers - Specialty & Generic	0.00%

Sichuan Huiyu Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2019–2024)

Sichuan Huiyu Pharmaceutical Co Ltd asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Sichuan Huiyu Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	13.33%	CN¥688.59 Million ≈ $100.76 Million	CN¥5.17 Billion ≈ $755.89 Million	-3.51pp
2023-12-31	16.84%	CN¥789.05 Million ≈ $115.46 Million	CN¥4.69 Billion ≈ $685.66 Million	-15.33pp
2022-12-31	32.17%	CN¥1.38 Billion ≈ $201.34 Million	CN¥4.28 Billion ≈ $625.79 Million	-8.08pp
2021-12-31	40.25%	CN¥1.66 Billion ≈ $243.23 Million	CN¥4.13 Billion ≈ $604.28 Million	+21.45pp
2020-12-31	18.80%	CN¥228.00 Million ≈ $33.36 Million	CN¥1.21 Billion ≈ $177.46 Million	-1.90pp
2019-12-31	20.70%	CN¥178.00 Million ≈ $26.05 Million	CN¥859.98 Million ≈ $125.84 Million	--

pp = percentage points

About Sichuan Huiyu Pharmaceutical Co Ltd

SHG:688553 China Drug Manufacturers - Specialty & Generic

Market Cap

$708.50 Million

CN¥4.84 Billion CNY

Market Cap Rank

#10145 Global

#2666 in China

Share Price

CN¥11.43

Change (1 day)

+0.26%

52-Week Range

CN¥9.86 - CN¥24.56

All Time High

CN¥38.07